Cambridge Investment Research Advisors’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$105K Hold
25,500
﹤0.01% 3927
2026
Q1
$92K Hold
25,500
﹤0.01% 3806
2025
Q4
$87K Sell
25,500
-500
-2% -$2.43K ﹤0.01% 3716
2025
Q3
$177K Buy
26,000
+500
+2% +$4.13K ﹤0.01% 3512
2025
Q2
$347K Hold
25,500
﹤0.01% 2861
2025
Q1
$139K Buy
25,500
+500
+2% +$2.84K ﹤0.01% 3293
2024
Q4
$124K Hold
25,000
﹤0.01% 3291
2024
Q3
$131K Sell
25,000
-200
-0.8% -$1.15K ﹤0.01% 3225
2024
Q2
$173K Buy
25,200
+200
+0.8% +$1.83K ﹤0.01% 3076
2024
Q1
$257K Hold
25,000
﹤0.01% 2832
2023
Q4
$207K Sell
25,000
-200
-0.8% -$1.44K ﹤0.01% 2875
2023
Q3
$158K Buy
25,200
+5,000
+25% +$21.7K ﹤0.01% 2883
2023
Q2
$88K Buy
20,200
+5,000
+33% +$11.1K ﹤0.01% 3024
2023
Q1
$26K Hold
15,200
﹤0.01% 3088
2022
Q4
$29K Buy
15,200
+200
+1% +$448 ﹤0.01% 3020
2022
Q3
$30K Sell
15,000
-1,204
-7% -$2.87K ﹤0.01% 2979
2022
Q2
$33K Buy
16,204
+1,204
+8% +$2.99K ﹤0.01% 2970
2022
Q1
$53K Buy
15,000
+1,000
+7% +$3.55K ﹤0.01% 3072
2021
Q4
$54K Buy
+14,000
New +$66.2K ﹤0.01% 3097

Other funds holding LFMD

Cambridge Investment Research Advisors's LFMD Position: Q2 2026 in Review

Cambridge Investment Research Advisors held its LifeMD (LFMD) position steady in Q2 2026 at 25,500 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #3927.

Cambridge Investment Research Advisors first reported a position in LFMD in Q4 2021 and has held it in 19 quarters since. The position peaked at $347K in Q2 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Cambridge Investment Research Advisors held 25,500 shares of LifeMD worth $105K as of Q2 2026.
  • Cambridge Investment Research Advisors left its LifeMD share count unchanged in Q2 2026.
  • LifeMD made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3927 holding.
  • Cambridge Investment Research Advisors first reported a position in LifeMD in Q4 2021 and has held it in 19 quarters since.
  • Cambridge Investment Research Advisors's LifeMD position peaked at $347K in Q2 2025.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.